Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byoung S Kwon

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Immunotherapy|January 27, 2018
Chimeric antigen receptor T-cell therapy for cancer: a basic research-oriented perspectiveChungyong Han, Byoung S Kwon
Cell Biology International|February 24, 2009
TNF superfamily: costimulation and clinical applicationsDass S Vinay, Byoung S Kwon
Cellular & Molecular Immunology|January 11, 2011
4-1BB signaling beyond T cellsDass S Vinay, Byoung S Kwon
Molecular Cancer Therapeutics|April 26, 2012
Immunotherapy of cancer with 4-1BBDass S Vinay, Byoung S Kwon
Immunotherapy|October 18, 2018
Harnessing immune checkpoints for cancer therapyDass S Vinay, Byoung S Kwon
Expert Opinion on Therapeutic Targets|October 3, 2015
Therapeutic potential of anti-CD137 (4-1BB) monoclonal antibodiesDass S Vinay, Byoung S Kwon
International Journal of Hematology|January 31, 2006
Immunotherapy targeting 4-1BB and its ligandDass S Vinay, Byoung S Kwon
Cellular Immunology|July 13, 2010
CD11c+CD8+ T cells: two-faced adaptive immune regulatorsDass S Vinay, Byoung S Kwon
Cytokine|January 3, 2012
Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritisDass S Vinay, Byoung S Kwon
BMB Reports|February 7, 2014
4-1BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapyDass S Vinay, Byoung S Kwon
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Immunotherapy|January 27, 2018
Chimeric antigen receptor T-cell therapy for cancer: a basic research-oriented perspectiveChungyong Han, Byoung S Kwon
Cell Biology International|February 24, 2009
TNF superfamily: costimulation and clinical applicationsDass S Vinay, Byoung S Kwon
Cellular & Molecular Immunology|January 11, 2011
4-1BB signaling beyond T cellsDass S Vinay, Byoung S Kwon
Molecular Cancer Therapeutics|April 26, 2012
Immunotherapy of cancer with 4-1BBDass S Vinay, Byoung S Kwon
Immunotherapy|October 18, 2018
Harnessing immune checkpoints for cancer therapyDass S Vinay, Byoung S Kwon
Expert Opinion on Therapeutic Targets|October 3, 2015
Therapeutic potential of anti-CD137 (4-1BB) monoclonal antibodiesDass S Vinay, Byoung S Kwon
International Journal of Hematology|January 31, 2006
Immunotherapy targeting 4-1BB and its ligandDass S Vinay, Byoung S Kwon
Cellular Immunology|July 13, 2010
CD11c+CD8+ T cells: two-faced adaptive immune regulatorsDass S Vinay, Byoung S Kwon
Cytokine|January 3, 2012
Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritisDass S Vinay, Byoung S Kwon
BMB Reports|February 7, 2014
4-1BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapyDass S Vinay, Byoung S Kwon
Pageof 15